Healthcare Global Enterprises Limited: Outcome of Board Meeting
Outcome of Board Meeting - Intimation regarding approval for investments in (i) HCG NCHRI Oncology LLP, wholly owned subsidiary for up to Rs. 98 Crore and (ii) Vizag Hospital and Cancer Research Centre Pvt Ltd (Vizag Hospital), a subsidiary of the Company for up to Rs. 155.66 crore for the acquisition of additional stake of 34% in the equity share capital of Vizag Hospital, directly from the selling shareholders..
SectorPharma & Healthcare
Value₹98 cr
Sources
- NSE filing - Healthcare Global Enterprises Limited · official
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026